Palisade Bio
PALI
6 hedge funds and large institutions have $68.5M invested in Palisade Bio in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
79% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $736K
50% more funds holding
Funds holding: 4 → 6 (+2)
39% more capital invested
Capital invested by funds: $49.5M → $68.5M (+$19.1M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.7M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$4.7M |
| 2 |
FAM
Fred Alger Management
New York
|
-$4.7M |
| 3 |
SFM
Soros Fund Management
New York
|
-$803K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$500K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$296K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
76
Tocqueville Asset Management
New York
| $4K | – | – | – |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | – | – | – |
|
|
AGM
78
Alpine Global Management
New York
| – | -$49K | – | – |
|
|
BG
79
BlackRock Group
London,
United Kingdom
| – | -$97K | – | – |
|
|
BCMU
80
BlueCrest Capital Management (UK)
St. Peter Port,
Guernsey
| – | -$176K | – | – |
|
|
CAS
81
CTC Alternative Strategies
Chicago,
Illinois
| – | -$90.9K | – | – |
|
|
HCM
82
Hollencrest Capital Management
Newport Beach,
California
| – | -$50K | – | – |
|
83
JP Morgan Chase
New York
| – | -$164K | – | – |
|
|
LP
84
LMR Partners
London,
United Kingdom
| – | -$296K | – | – |
|
|
PAM
85
Panagora Asset Management
Boston,
Massachusetts
| – | -$500K | – | – |
|
|
SFM
86
Soros Fund Management
New York
| – | -$803K | – | – |
|
|
STIA
87
Stone Toro Investment Advisers
Princeton,
New Jersey
| – | -$93K | – | – |
|
|
TC
88
TradeLink Capital
Chicago,
Illinois
| – | -$21K | – | – |
|
PALI Hedge Fund Activity: Q2 2014 in Review
6 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2014, worth a combined $68.5M — up 39% from $49.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PALI positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.7M. The largest seller was Credit Suisse, exiting entirely with an estimated $4.7M sold.
- 6 institutional investors held Palisade Bio (PALI) as of Q2 2014, up from 4 in Q1 2014.
- Funds reported $68.5M of Palisade Bio stock for Q2 2014, up 39% quarter-over-quarter.
- 3 funds opened new Palisade Bio positions in Q2 2014 and 1 closed out, a net change of +2 holders.
- The largest Palisade Bio buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.7M added.
- The largest Palisade Bio seller in Q2 2014 was Credit Suisse, an estimated $4.7M sold.
Based on aggregated 13F filings for Q2 2014.